Literature DB >> 27100655

Clinical Characteristics of Stenotrophomonas maltophilia Keratitis.

An-Lun Wu1, Lung-Kun Yeh, David H K Ma, Phil Y F Chen, Hsin-Chiung Lin, Chi-Chin Sun, Hsin-Yuan Tan, Hung-Chi Chen, Shin-Yi Chen, Ching-Hsi Hsiao.   

Abstract

PURPOSE: Stenotrophomonas maltophilia is an important opportunistic pathogen but an uncommon cause of corneal infections. This study aimed to report the clinical features, antibiotic susceptibility, treatments, and visual outcomes of S. maltophilia keratitis.
METHODS: The medical records of 21 patients with culture-proven S. maltophilia-associated infectious keratitis in our hospital between January 1, 2003, and December 31, 2014, were retrospectively reviewed. The clinical features of patients with S. maltophilia keratitis were compared with those of patients from 17 previously reported cases.
RESULTS: The most common risk factors for S. maltophilia keratitis were preexisting corneal disease or previous corneal surgery (16), followed by soft contact lens wear (9). Nine patients (42.9%) were multifactorial. Polymicrobial infections was detected in 12 eyes (57.1%). All S. maltophilia isolates were susceptible to levofloxacin and moxifloxacin. A total of 17 of 21 patients (81.0%) had favorable responses to topical antimicrobial treatment, and 10 (47.6%) required surgical intervention for promotion of reepithelialization (6) and corneal perforation (4). Final vision ranged from light perception to 20/20. The clinical features of S. maltophilia keratitis in our cases and in previously reported cases were similar.
CONCLUSIONS: S. maltophilia keratitis primarily affects patients with compromised ocular surfaces. S. maltophilia demonstrates in vitro susceptibility and a strong clinical response to fluoroquinolones.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27100655     DOI: 10.1097/ICO.0000000000000855

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  6 in total

1.  Clinical Features, Antibiotic Susceptibility Profile, and Outcomes of Infectious Keratitis Caused by Stenotrophomonas maltophilia.

Authors:  Sotiria Palioura; Allister Gibbons; Darlene Miller; Terrence P OʼBrien; Eduardo C Alfonso; Oriel Spierer
Journal:  Cornea       Date:  2018-03       Impact factor: 2.651

2.  Stenotrophomonas maltophilia: An emerging opportunistic nosocomial pathogen in a tertiary care hospital in Al Batinah North Governorate, Oman.

Authors:  Mohan B Sannathimmappa; Vinod Nambiar; Rajeev Aravindakshan; Nashwa M Al-Kasaby
Journal:  Sultan Qaboos Univ Med J       Date:  2021-03-15

3.  Clinical diagnosis and treatment of rare painless keratitis caused by three pathogens: clinical practice and experiential discussion.

Authors:  Yiming Sun; Wenjing Li; MiMi Wang; Quansheng Xing; Xuguang Sun
Journal:  J Int Med Res       Date:  2020-01       Impact factor: 1.671

4.  Clinical Features and Management of Stenotrophomonas Maltophilia Keratitis.

Authors:  B-C Park; Hwa-Rang Lim; Seon-Joo Park; Jae-Woong Koh
Journal:  Ophthalmol Ther       Date:  2021-05-13

5.  Advances in the Microbiology of Stenotrophomonas maltophilia.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2021-05-26       Impact factor: 50.129

6.  Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.

Authors:  Zhongliang Duan; Juanxiu Qin; Yao Liu; Cui Li; Chunmei Ying
Journal:  BMC Microbiol       Date:  2020-09-29       Impact factor: 3.605

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.